Skip to main content
. 2020 Jun 18;12(6):1612. doi: 10.3390/cancers12061612
AFP α-fetoprotein
ALP Alkaline phosphatase
BCLC Barcelona clinic liver cancer
CR Complete response
CT Computed tomography
CTCAE Common Toxicity Criteria for Adverse Events
CTV Clinical target volume
DLT Dose-limiting toxicity
ECOG Eastern Cooperative Oncology Group
HCC Hepatocellular carcinoma
IGRT Image-guided radiotherapy
IMRT Intensity-modulated radiotherapy
INR International normalized ratio
IRB Institutional Review Board
ITV Internal target volume
OAR Organs at risk
OS Overall survival
PD Progressive disease
PFS Progression-free survival
PR Partial response
PTV Planning target volume
RILD Radiation-induced liver disease
SBRT Stereotactic body radiotherapy
SD Stable disease
TACE Transarterial chemoembolization